BCL2 and ovarian carcinoma: The analysis of pulchrin A bound with Bcl-2 at the ABT-737 binding site suggests that pulchrin A shares a similar binding motif with ABT-737 in the BH3 domain of Bcl-2 and thus promotes apoptosis in human ovarian cancer cells.